In non-small cell lung cancer (NSCLC), USP7 was recently reported to deubiquitinate and stabilize estrogen receptor β (ERβ), and USP7-promoted ERβ stabilization is potentiated by ROS-induced stimulation. Here, ESR2 is linked to non-small cell lung carcinoma.